Amphastar Pharmaceuticals AMPH Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Amphastar Pharmaceuticals’s reported figures.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's gross profit?
- Amphastar Pharmaceuticals (AMPH) reported gross profit of $70.32M in Q1 2026.
- How has Amphastar Pharmaceuticals's gross profit changed year-over-year?
- Amphastar Pharmaceuticals's gross profit decreased by 17.5% year-over-year, from $85.25M to $70.32M.
- What is the long-term trend for Amphastar Pharmaceuticals's gross profit?
- Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's gross profit has grown at a 15.5% compound annual growth rate (CAGR), from $199.74M to $356.06M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.